| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |